Feasibility and efficacy of low‐dose pegfilgrastim for CD34 + cell mobilization in lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Feasibility and efficacy of low‐dose pegfilgrastim for CD34 + cell mobilization in lymphoma

Published:2020-07-29 Issue:5 Volume:35 Page:413-419
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J Clin Apher

Author:

Goto Hideki¹^ORCID,Hidaka Daisuke¹,Yamamoto Satoshi²,Hayasaka Koji³,Michimata Rie³,Kagawa Ikuko³,Sunagoya Kana³,Iijima Hiroaki⁴,Hayase Eiko¹,Shiratori Souichi¹,Okada Kohei¹,Sugita Junichi¹³,Onozawa Masahiro¹,Hashimoto Daigo¹,Kahata Kaoru¹⁴,Fujimoto Katsuya¹,Endo Tomoyuki¹,Shimizu Chikara³,Teshima Takanori¹³,

Affiliation:

1. Department of Hematology Faculty of Medicine, Graduate School of Medicine, Hokkaido University Sapporo Japan

2. Department of Hematology Sapporo City General Hospital Sapporo Japan

3. Division of Laboratory and Transfusion Medicine Hokkaido University Hospital Sapporo Japan

4. Clinical Research and Medical Innovation Center Hokkaido University Hospital Sapporo Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jca.21816

Reference19 articles.

1. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

2. High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin’s Lymphoma: Results From the Randomized European CUP Trial

3. Filgrastim (r-metHuG-CSF): the first 10 years

4. Pegfilgrastim

5. Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Single-dose Pegfilgrastim for CD34+ Cell Mobilization in Healthy Volunteers: A Phase 2 Study;Transplantation;2023-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3